Viable disc regenerative composition and method of manufacture and use
A viable disc regenerative composition has a micronized material of nucleus pulposus and a biological composition made from a mixture of mechanically selected allogeneic biologic material derived from bone marrow having non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components; and wherein the mixture is compatible with biologic function and further includes non-expanded whole cells. The biological composition is predisposed to demonstrate or support elaboration of active volume or spatial geometry consistent in morphology with that of disc tissue. The viable disc regenerative composition extends regenerative resonance that compliments or mimics disc tissue complexity.
1. A cryopreserved composition comprising:
i) a nucleus pulposus, wherein the nucleus pulposus is human-derived, dehydrated, and micronized;
ii) a bone-marrow-derived mixture of components including non-whole cellular components, the non-whole cellular components including vesicular components, active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components;
iii) a biologically compatible, polyampholyte, protectant or cryoprotectant; and
iv) optionally, saline.
2. The composition of claim 1 , wherein the composition further includes non-expanded, bone marrow-derived, whole cells.
3. The composition of claim 2 , wherein the non-expanded, bone marrow-derived, whole cells are being pluripotent stem cells.
4. The composition of claim 2 , wherein the non-expanded, bone marrow-derived, whole cells are non-differentiated, non-committed cells.
5. The composition of claim 1 , wherein the protectant or cryoprotectant creates a physical or electrical or chemical gradient or combination thereof for tissue regeneration.
6. The composition of claim 1 , further includes organelle fragments.
7. The composition of claim 1 , wherein the nucleus pulposus has particles sized less than 400 microns.
8. The composition of claim 7 , wherein the nucleus pulposus is a powder.
9. The composition of claim 1 , wherein the composition when rehydrated has a viscosity such that the composition is flowable through a 2-4 mm cannula.
10. The composition of claim 9 wherein the composition is contained in a syringe or other injectable device.
11. A kit comprising:
i) a quantity nucleus pulposus, wherein the nucleus pulposus is human-derived, dehydrated, and micronized; and
ii) a mixture comprising,
a) a bone-marrow-derived mixture of components including non-whole cellular components, the non-whole cellular components including vesicular components, active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components;
b) a biologically compatible polyampholyte protectant or cryoprotectant; and
iii) optionally, saline.